Summary. Cytochalasin B (200 ag/ml) completely inhibited the glucose-induced insulin release from isolated rat islets. Basal release was unaffected. The cytochalasininduced inhibition was rapidly reversible. Pretreatment with eytoehalasin B seemed to increase the sensitivity of islets to a subsequent glucose stimulation.
Involvement of microfilaments in the release of insulin has been suggested since cytochMasin B (CCB), a drug known to interfere with the organization of microfilaments [1, 2, 3] , was shown to stimulate glucose-induced insulin (IRI) release from rat pancreas [4, 5, 6, 7] . However, several reports on the inhibitory effect of CC]3 upon hormone release (growth hormone, norepinephrine, thyroxine) [8, 9, 10] , prompted us to restudy its effect on glucose-induced IgI release. A concentration-dependent stimulatory and inhibitory action was found.
Materials and Methods
Fed, male Wistar rats (200--250 g) were used throughout the study. CCB was purchased from Imperial ChemicM Industries Ltd, Macc]esfield, England; bovine serum Mbumin (.lot ORHD 20) from Behringwerke A.G. Marburg; iodinated insulin (.specific activity 150--200 mC/mg) from Farbwerke Hoechst A.G. Frankfurt; human insulin (lot 41-4866) from Novo Industri A.S. Copenhagen, Denmark; dimethylsulphoxide (DMSO) and all other reagents from E. Merck A.G., Darmstadt. Islets, isolated from rat pancreas by co]lagenase digestion [11] , were incubated at 37~ in a metabolic shaker (72 cycles/rain). All experiments were preceded by a preincubation of 15 rain. Incubations were in 500 ~1 Krebs-Ringer bicarbonate buffer (95% 02: 5% C02) containing bovine serum albumin (1 rag/ ml). Concentration of glucose and CCB is indicated in the tables. CCB was dissolved in DMSO; final concentration of DMSO 10 ~l/ml incubation medium. Groups of 10 islets were incubated for one or two periods of 45 rain. Between incubations islets were washed once with 1 ml Krebs-Ringer buffer. Insulin content of the media was determined by radioimmunoassay [12] with human insulin as reference standard. By appropriate dilutions of media Miquots all readings off the standard curve were done in that section (1--10 ~,U/ tube) that closely paralleled a standard curve established with rat insulin. IgI release was expressed as ~U/islet/45 rain. Table 1 , DMSO (10 ~l/ml) did not affect the glucose-induced IRI release from isolated rat islets. CCB had a dual effect. Depending on its concentration in the incubation medium IRI release was stimulated (10 ~g/ml) or inhibited (200 ~g/ml). "Basal insulin release" was unaffected since insulin output from islets incubated at a non stimulatory glucose concentration (2 mM) with or without cytoehalasin B (200 ~g/ml) was identical. Results demonstrating the reversibility of the CCBinduced inhibition of glucose-mediated IRI release are summarized in Table 2 . There was not only a complete recovery in the secretory capacity of CCB-pretreated islets but even an increased sensitivity to a subsequent glucose stimulation. Islets exposed in a first incubation (0--45 rain) to CCB (200 ~g/ml) did release more insulin during a second incubation (46--90 rain) in a CCB-free medium compared with controls. This was seen regardless of whether the glucose concentration during the first incubation (with CCB) was stimulatory (16.6 raM) or non stimulatory (2 mM).
Results

As indicated in
treatment with glucose could be due to an increased supply of glycolytic intermediates from glycogen stores [18] .
At present, the mode of action of CCB is unknown. A specific action upon the microfilamentous cell web from islet tissue has been suggested [4, 5, 6, 7] , but this seems unlikely in view of the fact that CCB influences the uptake of various substances (D-glucose, 2-deoxy- 
Discussion
CCB appears to interact with microfilaments0 a contractile system often found beneath cell membranes [1, 2, 3] . Since, following the administration of CCB, changes in the organization of the micro filamentous system of B cell membranes did coincide with an increased IRI release, involvement of microfilaments into the release mechanism was postulated [4, 5, 6, 7] . The stimUlatory effect of low concentrations of CCB (10 ~g/ml) on glucose-induced IRI release is confirmed. However, IgI release was abolished by high concentrations of CCB (200 ~g/ml) ( Table 1) . Although information on effects of CCB on the pancreatic B cell metabolism is scanty, permanent toxic effects can be ruled out since inhibition of IRI release was readily reversible (Table 2 ). Both the stimulatory and the inhibitory action of CCB are apparent in the presence of high glucose concentrations only. Insulin release under "basal conditions", i.e. in the presence of low non-stimulating glucose concentrations, was neither stimulated nor impaired, as shown in this report and by previous investigators [4] . CCB may therefore be characterized as a modifier of glucose-induced II~I release.
The glucose-induced secretory response in control islets was larger after preincubation with 16.6 mM glucose than after preincubation with 2.0 mM glucose (Table 2 ). An analogous observation has been made with microdissected islets from obese-hyperglycemic mice [18] . Since exposure to glucose is known to increase the glycogen level in islets of obese mice [19] , it was proposed that the elevated IRI release after pre-D-glucose, D-glueosamine, orotic acid, uridine, thymidine) into several lines of mammalian cells, thus indicating an effect upon cell membranes [13, 14, 15, 16, 17] . The rapidity with which CCB affects the transport of these substances is also compatible with a membrane-directed action [16, 17] . The rapid induction and reversion of the stimulatory and inhibitory effects of CCB on IRI release supports this assumption, as well as the finding that pretreatment with CCB seems to increase the sensitivity of islets to glucose ( Table 2) .
As long as a specific action of CCB upon the microfilamentous cell web from islet tissue is doubtful, it remains questionable to what extent the observed effects of CCB on IRI release can be used as an argument for the involvement of the microfilamentous system into the process of insulin release.
